glp 1 drugs adverse effects A Retrospective Comparative Analysis of Cutaneous Reactions in GLP-1 Agonist Therapies - JDDonline GLP-1 Side Effects: 7 Important

The ADA notes that medication adjustments should be individualized based on the patient's glycemic control, with appropriate glucose monitoring during any interruption period

Activation of GLP-1R also triggers the PI3K/Akt signaling pathway via the subunits of G proteins, thereby promoting -cell viability and replicative capacity ( 2.2 Inflammation and immune modulation Recent preclinical studies have demonstrated its bidirectional immunomodulatory effects, including improvement of organ dysfunction, regulation of immune responses, and mitigation of sepsis-associated cytokine storms, mediated through anti-inflammatory and anti-apoptotic pathways

GLP-1 based therapies: differential effects on fasting and postprandial glucose

The incretin-related therapies dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) not only improve glycaemic control with a low risk of hypoglycaemia but can also have beneficial non-glycaemic effects such as avoidance of weight gain, reduced blood pressure and improvements in beta-cell function and cardiovascular risk biomarkers 1 3

Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K, Konakli K, et al

The literature search and data extraction were performed by the authors